Engagement Manager · Apex Strategy Group

Turning oncology conference intelligence into competitive advantage

I lead competitive intelligence engagements across the global oncology landscape, translating real-time conference data, pipeline shifts, and stakeholder dynamics into strategies that sharpen positioning and accelerate decisions for biopharma clients.

Apex Strategy Group, a global strategic consultancy with ~500 experts across 7 cities, partnering with 27 of the top 30 biopharma companies worldwide.

Connect on LinkedIn

Connect on LinkedIn
12+
Major Conferences Covered Annually
6+
Therapeutic Areas
5+
Continents Covered
27
Top 30 Biopharma Clients
About
Where scientific depth meets strategic clarity

As an Engagement Manager at Apex Strategy Group, I sit at the nexus of scientific analysis and competitive strategy in oncology. My work involves designing and leading intelligence programs that track the evolving competitive dynamics across some of the most complex and fast-moving therapeutic areas in biopharma.

From pre-conference planning through real-time intelligence capture to post-congress strategic synthesis, I ensure that every data readout, every KOL reaction, and every pipeline signal is contextualized and translated into actionable strategic recommendations for our biopharma clients.

Working within Apex Strategy's global network spanning London, New York, San Francisco, New Delhi, and beyond, I bring both the analytical rigor of competitive intelligence and the consultative depth needed to inform decisions that shape product strategies from early pipeline through post-launch.

Competitive Intelligence Leadership

Designing and executing multi-asset CI programs with cross-functional teams, delivering insights that directly influence clinical and commercial strategy.

Conference Analytics & Coverage

Comprehensive pre-, peri-, and post-conference intelligence across ASCO, ESMO, AACR, ASH, WCLC, SABCS, and specialty oncology meetings globally.

Strategic Stakeholder Engagement

Managing client relationships and translating complex competitive landscapes into clear, evidence-based recommendations for senior biopharma decision-makers.

Global Oncology Expertise

Deep understanding of oncology competitive dynamics including immunotherapy, ADCs, bispecifics, radiopharmaceuticals, and precision medicine modalities.

Core Expertise
Intelligence that moves the needle
Every engagement is designed to deliver evidence-based strategic insight: not reports, but decisions.

Competitive Landscape Assessment

Mapping the competitive, regulatory, and market environment to identify key players, emerging trends, and disruptors, creating holistic, forward-looking competitor dossiers backed by clinical and commercial data.

Congress Intelligence Programs

End-to-end conference coverage from abstract prioritization to real-time insights to post-event strategic synthesis across all major oncology congresses including ASCO, ESMO, AACR, ASH, WCLC, and SABCS.

War Gaming & Scenario Planning

Facilitating cross-functional workshops that predict competitors' likely actions and develop strategic responses, building organizational confidence through structured threat assessment and scenario analysis.

Pipeline & Asset Tracking

Dynamic monitoring of competitor pipelines across clinical stages, tracking data readouts, regulatory milestones, label expansions, and commercial strategy signals that impact product positioning.

Stakeholder Perception Analysis

Capturing and analyzing KOL and healthcare stakeholder perceptions through primary and secondary research to inform positioning, messaging strategy, and clinical differentiation.

Product Differentiation Strategy

Identifying opportunities to maximize competitive advantage across clinical data, value propositions, and franchise strategies, spanning early clinical development through loss of exclusivity.

Global Conference Coverage
On the ground where oncology decisions are made
Major oncology conferences are where paradigm-shifting data emerges, and where competitive dynamics crystallize in real time. I cover these events to deliver intelligence when it matters most.
ASCO

American Society of Clinical Oncology

The premier global oncology meeting where treatment standards shift and drug developers' fortunes are shaped.

📍 Chicago, IL · May-June
ESMO

European Society for Medical Oncology

Europe's leading oncology congress, increasingly featuring breakthroughs in ADCs, radiopharmaceuticals, and immunotherapy.

📍 Madrid, 2026 · October
AACR

American Association for Cancer Research

A critical forum for earlier-stage cancer science: novel mechanisms, translational breakthroughs, and emerging modalities.

📍 San Diego, 2026 · April
ASH

American Society of Hematology

The definitive meeting for hematologic malignancies: leukemias, lymphomas, myeloma, and cell therapies.

📍 New Orleans, 2026 · December
WCLC

World Conference on Lung Cancer

The top conference for lung cancer advances, including the competitive PD-1/VEGF inhibitor landscape reshaping treatment paradigms.

📍 Seoul, 2026 · September
SABCS

San Antonio Breast Cancer Symposium

The foremost breast cancer conference globally, driving treatment advances from early-stage to metastatic disease.

📍 San Antonio, TX · December
SITC

Society for Immunotherapy of Cancer

Focused on immuno-oncology innovation: checkpoint therapies, CAR-T, bispecifics, and emerging combinations.

📍 Phoenix, AZ · November
EHA

European Hematology Association

A premier meeting for hematology research, featuring cutting-edge data on blood cancers and novel cellular therapies.

📍 Stockholm, 2026 · June
The Intelligence Lifecycle
From data to decision: a structured approach
Competitive intelligence isn't about volume of information. It's about surfacing the insight that changes the conversation.
Phase 01: Pre-Conference

Strategic Planning & Prioritization

Aligning coverage objectives with client strategy, identifying key abstracts, competitor assets, KOL activities, and satellite events to maximize intelligence value before the conference begins.

Phase 02: Peri-Conference

Real-Time Intelligence Capture

On-ground intelligence gathering across oral sessions, poster presentations, industry symposia, and informal KOL interactions, delivering real-time insights and competitive signals as they emerge.

Phase 03: Post-Conference

Strategic Synthesis & Implications

Translating raw conference intelligence into contextualized strategic analysis, assessing competitive impact, updating landscape assessments, and delivering implications-driven reports that inform cross-functional decision-making.

Phase 04: Ongoing

Continuous Monitoring & Advisory

Maintaining dynamic competitive dashboards, tracking pipeline milestones between congresses, and providing ad-hoc intelligence briefings as market dynamics evolve, ensuring clients are never caught off guard.

Therapeutic Coverage
Deep oncology expertise, broad therapeutic fluency
Focused on oncology and hematology, with intelligence capabilities spanning the most competitive and fast-evolving therapeutic spaces.

Solid Tumors

NSCLC · Breast · CRC · RCC

Hematologic Malignancies

AML · CLL · MM · NHL

Immuno-Oncology

Checkpoint · CAR-T · Bispecifics

Precision Medicine

Biomarkers · MRD · Companion Dx

Novel Modalities

ADCs · Radiopharm · mRNA

GI Oncology

Gastric · HCC · Pancreatic · Esophageal

Thought Leadership
Insights & Intelligence
Perspectives on competitive dynamics, emerging modalities, and the evolving oncology landscape, published through Apex Strategy Group.
Conference Report

ASCO 2025: Key Competitive Dynamics in NSCLC

An analysis of the shifting competitive landscape in non-small cell lung cancer, including updated survival data from PD-1/VEGF combinations and the emerging ADC pipeline.

June 2025 · Apex Strategy Read more →
Competitive Analysis

The ADC Arms Race: Navigating a Crowded Landscape

A deep-dive into the antibody-drug conjugate competitive landscape: differentiating profiles, payload mechanisms, and the race for combination regimens across solid tumors.

April 2025 · Apex Strategy Read more →
Strategic Perspective

War Gaming in Oncology: Why Most Simulations Fall Short

Why traditional scenario planning underestimates competitor agility in oncology. Intelligence-led war gaming closes the gap between prediction and preparedness.

February 2025 · Apex Strategy Read more →
Market Intelligence

Radiopharmaceuticals: From Niche to Mainstream

How targeted radiotherapy is reshaping competitive dynamics in prostate and neuroendocrine tumors, tracking the key players, emerging combinations, and regulatory trajectories.

November 2024 · Apex Strategy Read more →
What Clients Say
Impact that speaks for itself
Feedback from biopharma colleagues and clients across competitive intelligence and strategic advisory engagements.

"John's ASCO briefings are consistently the most actionable intelligence we receive from any partner. She doesn't just report what happened; she tells us what it means for our asset."

S
Senior Director, Competitive Intelligence
Top 10 Global Biopharma Company

"The war gaming workshop she facilitated ahead of our launch was genuinely transformative. The team walked out with clarity on competitive scenarios we hadn't even considered."

M
VP, Global Commercial Strategy
Mid-Sized Oncology Biotech

"What sets John apart is her ability to synthesize complex scientific data and translate it into strategic implications in real time. Invaluable at major conferences."

R
Head of CI, Oncology Franchise
Global Pharmaceutical Company
Get in Touch
Looking to strengthen your oncology competitive intelligence?

Whether it's conference coverage strategy, competitive landscape assessments, war gaming facilitation, or ongoing pipeline intelligence. I'd welcome the conversation. Let's explore how Apex Strategy Group can support your team.

john@apexstrategy.com Direct email
LinkedIn Profile Connect professionally
🌐
apexstrategy.com London · New York · New Delhi

Your information is kept confidential and used only to respond to your inquiry.

✓ Message sent. I'll be in touch within 1 to 2 business days.